Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
COA published
- Arrives Thu, Oct 22 – Tue, Oct 27Free standard shipping on orders over $100
- Free shipment protectionLost, stolen, or damaged? We replace it, on us.
- Overnight and 2-day optionsPick your speed at checkout
GLP-3 (RT)
Triple-Action Metabolic Compound
A 39-residue peptide that activates three receptors at once: GIP, GLP-1 and glucagon. It is used in metabolic research on how combined incretin and glucagon signaling affects energy expenditure, lipid handling and body weight in animal models. For in vitro laboratory research use only.
- Arrives Thu, Oct 22 – Tue, Oct 27Free standard shipping on orders over $100
- Free shipment protectionLost, stolen, or damaged? We replace it, on us.
- Overnight and 2-day optionsPick your speed at checkout
Certificate of Analysis
Third Party Tested ISO/IEC 17025 ACCREDITED
✓ Passed full QC panel
Compound Information
What is GLP-3 (RT)?
- CAS number
- 2381089-83-2
- Molecular weight
- 4,731.33 g/mol
- Amino acids
- 39
- Formula
- C221H342N46O68
- Sequence
- 39-residue triple agonist; Aib at 2 and 20; alpha-Me-Leu at 13; C20 diacid on Lys17 via gamma-Glu + AEEA; C-terminal amide
Stability information
- Protect from light
- Avoid repeated freeze-thaw cycles
Conditions apply to sealed research vials as supplied. Batch details are on the Certificate of Analysis above.
Sources & References
Peer-reviewed research
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source ↗GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source ↗A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
View Source ↗Frequently Researched Together
Related research compounds
Recon Water
Research Supplies
Tesamorelin
GHRH analog
IGF-1 LR3
Long-acting IGF-1 analog
Epithalon
Tetrapeptide research compound
AOD-9604
Cellular Peptide
SELANK
Anxiolytic research peptide
TB-500
Actin-binding research peptide
Pinealon
Cognitive Peptide
Thymosin Alpha-1
Immunomodulatory peptide